Point72 Asset Management Portfolio holdings
AUM
$42.3B
1-Year Return
23.07%
This Quarter Return
-12.09%
1 Year Return
+23.07%
3 Year Return
+96.14%
5 Year Return
+182.48%
10 Year Return
+383.75%
AUM
$21.3B
AUM Growth
-$1.31B
(-5.8%)
Cap. Flow
+$990M
Cap. Flow
% of AUM
4.65%
Top 10 Holdings %
Top 10 Hldgs %
9.89%
Holding
1,460
New
296
Increased
332
Reduced
261
Closed
316
Top Buys
| 1 |
T-Mobile US
TMUS
|
$207M |
| 2 |
Take-Two Interactive
TTWO
|
$166M |
| 3 |
CrowdStrike
CRWD
|
$138M |
| 4 |
ServiceNow
NOW
|
$136M |
| 5 |
Domino's
DPZ
|
$133M |
Top Sells
| 1 |
Merck
MRK
|
$217M |
| 2 |
Target
TGT
|
$169M |
| 3 |
Booking.com
BKNG
|
$158M |
| 4 |
FedEx
FDX
|
$156M |
| 5 |
Cenovus Energy
CVE
|
$155M |
Sector Composition
| 1 | Healthcare | 23.55% |
| 2 | Technology | 18.1% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Financials | 7.99% |
| 5 | Industrials | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
AT&T
T
$212B
| $17.2M | 0.07% |
820,100
+690,480
| +533% | +$14.5M |
|
327
Targa Resources
TRGP
$34.9B
| $17.1M | 0.07% |
287,342
-820,439
| -74% | -$49M |
|
328
Axogen
AXGN
$735M
| $17.1M | 0.07% |
+2,085,881
| New | +$17.1M |
|
|
NGM
329
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $16.9M | 0.07% |
1,320,662
-1,890,209
| -59% | -$24.2M |
|
330
Entergy
ETR
$39.2B
| $16.9M | 0.07% |
300,400
-1,957,400
| -87% | -$110M |
|
331
NeoGenomics
NEO
$1.03B
| $16.9M | 0.07% |
+2,075,433
| New | +$16.9M |
|
332
Interactive Brokers
IBKR
$26.8B
| $16.9M | 0.07% |
+1,228,408
| New | +$16.9M |
|
333
Civitas Resources
CIVI
$3.19B
| $16.9M | 0.07% |
+322,500
| New | +$16.9M |
|
334
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.51B
| $16.9M | 0.07% |
+445,100
| New | +$16.9M |
|
335
Factset
FDS
$14B
| $16.8M | 0.07% |
43,728
+22,199
| +103% | +$8.54M |
|
336
Air Products & Chemicals
APD
$64.5B
| $16.7M | 0.07% |
69,570
-16,330
| -19% | -$3.93M |
|
337
Pembina Pipeline
PBA
$22.1B
| $16.6M | 0.07% |
469,800
-400
| -0.1% | -$14.1K |
|
338
Bausch Health
BHC
$2.72B
| $16.6M | 0.07% |
+1,981,800
| New | +$16.6M |
|
339
Cytek Biosciences
CTKB
$511M
| $16.5M | 0.07% |
1,536,079
+905,079
| +143% | +$9.71M |
|
340
Ultragenyx Pharmaceutical
RARE
$3.07B
| $16.3M | 0.07% |
273,515
-44,982
| -14% | -$2.68M |
|
341
Crocs
CROX
$4.72B
| $15.9M | 0.07% |
327,476
+237,802
| +265% | +$11.6M |
|
|
PXD
342
DELISTED
Pioneer Natural Resource Co.
PXD
| $15.9M | 0.07% |
71,137
-407,731
| -85% | -$91M |
|
|
RADI
343
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $15.8M | 0.07% |
1,036,217
+392,295
| +61% | +$5.99M |
|
344
Sanofi
SNY
$113B
| $15.8M | 0.07% |
315,984
-1,009,647
| -76% | -$50.5M |
|
345
Armstrong World Industries
AWI
$8.58B
| $15.8M | 0.07% |
210,539
-82,761
| -28% | -$6.2M |
|
346
Marsh & McLennan
MMC
$100B
| $15.7M | 0.07% |
101,400
-45,045
| -31% | -$6.99M |
|
|
AAC
347
DELISTED
Ares Acquisition Corporation
AAC
| $15.7M | 0.07% |
1,600,000
| – | – |
|
348
Zoom
ZM
$25B
| $15.7M | 0.07% |
+145,424
| New | +$15.7M |
|
349
UDR
UDR
$13B
| $15.4M | 0.07% |
+335,385
| New | +$15.4M |
|
350
AMN Healthcare
AMN
$799M
| $15.3M | 0.06% |
139,900
+53,800
| +62% | +$5.9M |
|